Annual Report 2022

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2022 114 The United Laboratories International Holdings Limited Annual Report 2022 22. FINANCIAL ASSET AT FAIR VALUE THROUGH PROFIT OR LOSS 2022 2021 RMB’000 RMB’000 Equity securities of unlisted investments, classified as non-current assets 500 500 The above unlisted equity investments represent the Group’s equity interest in a private entity established in the PRC, which are measured at FVTPL at the end of both reporting periods. 23. INVENTORIES 2022 2021 RMB’000 RMB’000 Raw materials 844,959 641,560 Work in progress 231,377 169,793 Finished goods 1,087,290 1,192,676 2,163,626 2,004,029 24. TRADE AND BILLS RECEIVABLES, OTHER RECEIVABLES, DEPOSITS AND PREPAYMENTS 2022 2021 RMB’000 RMB’000 Trade receivables from contracts with customers 2,110,751 1,624,198 Less: allowance for credit losses (6,839) (22,309) Banker’s acceptance bills receivables 2,360,224 1,821,768 Less: allowance for credit losses (848) – Commercial bills receivables 18,909 – Less: allowance for credit losses (6,375) – Consideration receivables (Note 10) 339,574 339,574 Less: allowance for credit losses (339,574) (339,574) Value added tax receivables 115,866 103,214 Other receivables, deposits and prepayments 326,512 283,001 Less: allowance for credit losses (6,496) (9,967) 4,911,704 3,799,905 At 1 January 2021, gross carrying amount of trade receivables from contracts with customers amounted to RMB1,420,450,000.